miR-200 Regulates PDGF-D-Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells
Open Access
- 23 April 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 27 (8) , 1712-1721
- https://doi.org/10.1002/stem.101
Abstract
MicroRNAs have been implicated in tumor progression. Recent studies have shown that the miR-200 family regulates epithelial–mesenchymal transition (EMT) by targeting zinc-finger E-box binding homeobox 1 (ZEB1) and ZEB2. Emerging evidence from our laboratory and others suggests that the processes of EMT can be triggered by various growth factors, such as transforming growth factor β and platelet-derived growth factor-D (PDGF-D). Moreover, we recently reported that overexpression of PDGF-D in prostate cancer cells (PC3 PDGF-D cells) leads to the acquisition of the EMT phenotype, and this model offers an opportunity for investigating the molecular interplay between PDGF-D signaling and EMT. Here, we report, for the first time, significant downregulation of the miR-200 family in PC3 PDGF-D cells as well as in PC3 cells exposed to purified active PDGF-D protein, resulting in the upregulation of ZEB1, ZEB2, and Snail2 expression. Interestingly, re-expression of miR-200b in PC3 PDGF-D cells led to reversal of the EMT phenotype, which was associated with the downregulation of ZEB1, ZEB2, and Snail2 expression, and these results were consistent with greater expression levels of epithelial markers. Moreover, transfection of PC3 PDGF-D cells with miR-200b inhibited cell migration and invasion, with concomitant repression of cell adhesion to the culture surface and cell detachment. From these results, we conclude that PDGF-D-induced acquisition of the EMT phenotype in PC3 cells is, in part, a result of repression of miR-200 and that any novel strategy by which miR-200 could be upregulated would become a promising approach for the treatment of invasive prostate cancer. Disclosure of potential conflicts of interest is found at the end of this article.Keywords
Funding Information
- National Cancer Institute, NIH (5R01CA108535)
- Puschelberg Foundation
This publication has 39 references indexed in Scilit:
- Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epitheliumAmerican Journal of Physiology-Cell Physiology, 2006
- SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctionsNucleic Acids Research, 2005
- Structural and functional specificities of PDGF‐C and PDGF‐D, the novel members of the platelet‐derived growth factors familyThe FEBS Journal, 2005
- Platelet-Derived Growth Factor D Is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma CellsMolecular and Cellular Biology, 2005
- DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cellsOncogene, 2005
- A Potential Oncogenic Activity of Platelet-Derived Growth Factor D in Prostate Cancer ProgressionCancer Research, 2004
- PDGF-D is a potent transforming and angiogenic growth factorOncogene, 2003
- Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformationKidney International, 2002
- Role of phosphoinositide 3OH‐kinase in autocrine transformation by PDGF‐BB*Journal of Cellular Physiology, 2001
- The Zinc-Finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor–induced Epithelial–Mesenchymal TransitionThe Journal of cell biology, 1997